Učitavanje...
Hepatitis C: Treatment of difficult to treat patients
Over the past several years, more so recently, treatment options for hepatitis C virus (HCV) have seemed to exponentially grow. Up until recently, the regimen of pegylated interferon (peg-IFN) and ribavirin (RBV) stood as the standard of care. Direct acting antivirals, which target nonstructural pro...
Spremljeno u:
| Izdano u: | World J Hepatol |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Baishideng Publishing Group Inc
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4517154/ https://ncbi.nlm.nih.gov/pubmed/26244069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v7.i15.1953 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|